UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

PloS one, 2018-10, Vol.13 (10), p.e0205368-e0205368

2018

Volltextzugriff (PDF)

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany

PloS one, 2014-08, Vol.9 (8), p.e104474-e104474

2014

Volltextzugriff (PDF)

Human immunodeficiency virus infection in the elderly

Zeitschrift für Gerontologie und Geriatrie, 2020-03, Vol.53 (2), p.179

Bogner, Johannes R

2020

Volltextzugriff (PDF)

Biomarkers and Electrocardiographic Evidence of Myocardial Ischemia in Patients With Human Immunodeficiency Virus Infection

The American journal of cardiology, 2013-03, Vol.111 (5), p.760-764

2013

Volltextzugriff (PDF)

Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance

Clinical infectious diseases, 2010-03, Vol.50 (6), p.890-894

2010

Volltextzugriff (PDF)

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2092-2098

2011

Volltextzugriff (PDF)

Nevirapine extended-release for the treatment of HIV-1 infection

Expert review of anti-infective therapy, 2012-01, Vol.10 (1), p.21-30

Bogner, Johannes R

2012

Volltextzugriff (PDF)

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity

Antiviral therapy, 2012-01, Vol.17 (4), p.689-700

2012

Volltextzugriff (PDF)

Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology

Antiviral therapy, 2013-01, Vol.18 (2), p.193-204

2013

Volltextzugriff (PDF)

Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients

Current HIV research, 2009-05, Vol.7 (3), p.336-339

2009

Volltextzugriff (PDF)

Stavudine versus zidovudine and the development of lipodystrophy

Journal of acquired immune deficiency syndromes (1999), 2001-07, Vol.27 (3), p.237-244

2001

Volltextzugriff (PDF)

Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy

Antiviral therapy, 2010-01, Vol.15 (4), p.563-570

2010

Volltextzugriff (PDF)

This far it can go without HIV therapy!

MMW Fortschritte der Medizin, 2016-06, Vol.158 Suppl 1, p.7-7

2016

Volltextzugriff (PDF)

An Unusual Cluster of Cases of Castleman's Disease during Highly Active Antiretroviral Therapy for AIDS

The New England journal of medicine, 1999-06, Vol.340 (24), p.1923-1924

1999

Volltextzugriff (PDF)

The ageing HIV-patient: what to do with comorbidities?

MMW Fortschritte der Medizin, 2012-05, Vol.154 Suppl 1, p.16-16

Bogner, Johannes R

2012

Volltextzugriff (PDF)

Organic psychoses in HIV-infected patients--an interdisciplinary case report

MMW Fortschritte der Medizin, 2014-06, Vol.156 Suppl 1, p.22-23

2014

Volltextzugriff (PDF)

Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy

AIDS (London), 2001-01, Vol.15 (1), p.33-45

2001

Volltextzugriff (PDF)

Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK

Antiviral therapy, 2006-01, Vol.11 (8), p.1071-1080

2006

Volltextzugriff (PDF)

Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients

European journal of medical research, 2007-02, Vol.12 (2), p.54

2007

Volltextzugriff (PDF)

Integrase inhibition

MMW Fortschritte der Medizin, 2009-04, Vol.151 (18), p.68

Bogner, Johannes R

2009

Volltextzugriff (PDF)

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

Journal of acquired immune deficiency syndromes (1999), 2020-05, Vol.84 (1), p.60-65

2020

Volltextzugriff (PDF)

Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability

AIDS research and human retroviruses, 2001-07, Vol.17 (11), p.1035-1039

2001

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

KollektionWiley Online Library

ThemaFamily Medicine

ThemaInternal Medicine

ThemaAnti-Hiv Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(18)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Science & Technology
(19)
Hiv Infections - Drug Therapy
(18)
Life Sciences & Biomedicine
(17)
Male
(17)
Adult
(16)
Middle Aged
(16)
Female
(14)
Infectious Diseases
(13)
Anti-Hiv Agents - Adverse Effects
(8)
Biological And Medical Sciences
(8)
Hiv
(8)
Medical Sciences
(8)
Virology
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(7)
Antiviral Agents
(7)
Drug Therapy, Combination
(7)
Human Immunodeficiency Virus
(7)
Immunology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany

Human immunodeficiency virus infection in the elderly

Biomarkers and Electrocardiographic Evidence of Myocardial Ischemia in Patients With Human Immunodeficiency Virus Infection

Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens

Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial

Nevirapine extended-release for the treatment of HIV-1 infection

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity

Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology

Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients

Stavudine versus zidovudine and the development of lipodystrophy

Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy

This far it can go without HIV therapy!

An Unusual Cluster of Cases of Castleman's Disease during Highly Active Antiretroviral Therapy for AIDS

The ageing HIV-patient: what to do with comorbidities?

Organic psychoses in HIV-infected patients--an interdisciplinary case report

Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy

Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK

Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients

Integrase inhibition

Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis

Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability

Aktive Filter

Suchergebnisse filtern